Menu
2 More Days to Apply to the VITAL Biotech Accelerator Program and Non-dilutive Funding Opportunities!
VITAL is a new accelerator hub in the U.S. Biomedical Advanced Research and Development Authority (BARDA) Accelerator Network (BAN). The BAN fosters growth of the global health security innovation ecosystem by supporting early-stage companies to overcome their business, marketing, and operational hurdles. VITAL supports development of next-generation therapeutic and vaccine technologies and platforms to promote health security, and is operated by Start2 Group, Advise Connect Inspire (ACI), and BioLabs.
VITAL supports health security innovators, startups, and portfolio companies by providing wraparound accelerator services including entrepreneurship education and access to technical and business/commercialization expertise and resources.
VITAL provides non-dilutive funding to startups to perform development, evaluation, and validation services for novel vaccine and therapeutic medical countermeasures that align with BARDA’s strategic priorities.
In the event of a Public Health Emergency, the BARDA Accelerator Network, including the VITAL Hub, can rapidly fund and accelerate product development and validation of medical countermeasures that can be developed and deployed as quickly as possible.
The Accelerator Program and DEV Awards are set to kick off in October of 2024.
Are you a startup or university-based project pioneering the future of therapeutics and vaccines? We’re looking for innovative solutions that align with BARDA’s mission to enhance pandemic preparedness and health security. Apply to the VITAL Biotech Accelerator Program and make a global impact! Application Deadline: August 23.
Are you working on groundbreaking therapeutics or vaccine solutions? VITAL invites startups and university-backed projects to apply for non-dilutive funding ranging from $50K to $200K. This funding supports the development, evaluation, or validation of innovative solutions aligned with BARDA’s mission to enhance pandemic preparedness and health security. Application Deadline: August 23.
Watch our info session to gain insights into the VITAL Biotech Accelerator Program and Funding opportunities.
Join us at the BARDA VITAL Hub Symposium in Berlin for cutting-edge insights on advancements in pandemic preparedness to combat infectious diseases and enhance global health security. Connect with global experts from the U.S., Canada, and EU to explore the latest discoveries and strategies in preventing and addressing global health crises.
Special Populations
Enabling Technologies